Seeking Novel Research Programmes to Induce Specific Tregs in vivo
This campaign has been commissioned by an international Japanese pharmaceutical company who combat diseases using a combination of ground‑breaking technology and biology, with an extensive track record of academic collaboration. They are seeking novel research programs which can induce tissue/antigen‑specific regulatory T cells in vivo for immune disorders.
Specific Points of Interest
- Biology that can induce tissue or antigen specific regulatory T cells in vivo. In addition to Treg cell number, it is preferable to have functional data of induced Tregs ...
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile